Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Arning M., Dresen B., Aul C., Schneider W. Influence of infusion time on the acute toxicity of amphotericin B: results of a randomized double-blind study. Recent Results Cancer Res. 1991;121:347–352. doi: 10.1007/978-3-642-84138-5_41. [DOI] [PubMed] [Google Scholar]
- Cleary J. D., Weisdorf D., Fletcher C. V. Effect of infusion rate on amphotericin B-associated febrile reactions. Drug Intell Clin Pharm. 1988 Oct;22(10):769–772. doi: 10.1177/106002808802201005. [DOI] [PubMed] [Google Scholar]
- Craven P. C., Gremillion D. H. Risk factors of ventricular fibrillation during rapid amphotericin B infusion. Antimicrob Agents Chemother. 1985 May;27(5):868–871. doi: 10.1128/aac.27.5.868. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ellis M. E., al-Hokail A. A., Clink H. M., Padmos M. A., Ernst P., Spence D. G., Tharpe W. N., Hillier V. F. Double-blind randomized study of the effect of infusion rates on toxicity of amphotericin B. Antimicrob Agents Chemother. 1992 Jan;36(1):172–179. doi: 10.1128/aac.36.1.172. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Oldfield E. C., 3rd, Garst P. D., Hostettler C., White M., Samuelson D. Randomized, double-blind trial of 1- versus 4-hour amphotericin B infusion durations. Antimicrob Agents Chemother. 1990 Jul;34(7):1402–1406. doi: 10.1128/aac.34.7.1402. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Spitzer T. R., Creger R. J., Fox R. M., Lazarus H. M. Rapid infusion amphotericin B: effective and well-tolerated therapy for neutropenic fever. Pharmatherapeutica. 1989;5(5):305–311. [PubMed] [Google Scholar]